Changes in Therapy Recommendations in the 2019 ATS/IDSA Guidelines for Community-Acquired Pneumonia
https://www.contagionlive.com/news/changes-in-therapy-recommendations-in-the-2019-atsidsa-guidelines-for-communityacquired-pneumoniaIDWeek 2019 News Network: Areas of Improvement for CAP Guidelines
https://www.contagionlive.com/insights/idweek-news-network-2019/idweek-2019-news-network-areas-of-improvement-for-cap-guidelinesOASIS Pooled Results: Omadacycline Safe and Efficacious in IVDU and non-IVDU
https://www.contagionlive.com/news/oasis-pooled-results-omadacycline-safe-and-efficacious-in-ivdu-and-nonivduScience world mourns passing of prominent voice on antibiotic resistance | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/09/science-world-mourns-passing-prominent-voice-antibiotic-resistanceStewardship / Resistance Scan for Aug 30, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/08/stewardship-resistance-scan-aug-30-2019The Lancet Infectious Diseases Publishes Results from Paratek’s Phase 3 Oral only Dosing Study of NUZYRA® (omadacycline) for Skin Infections Nasdaq:PRTK
https://www.globenewswire.com/news-release/2019/08/30/1909018/0/en/The-Lancet-Infectious-Diseases-Publishes-Results-from-Paratek-s-Phase-3-Oral-only-Dosing-Study-of-NUZYRA-omadacycline-for-Skin-Infections.html